Effect of immunosuppressive therapy in infl ammatory cardiomyopathy: data from The Czech Inflammatory Cardiomyopathy Immunosuppressive Trial.

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209775%3A_____%2F22%3AN0000026" target="_blank" >RIV/00209775:_____/22:N0000026 - isvavai.cz</a>

Alternative codes found

RIV/00159816:_____/22:00075821 RIV/00216224:14110/22:00128010

Result on the web

<a href="http://www.elis.sk/download_file.php?product_id=7503&session_id=p837ql6mq8aer9601ekbmlrve6" target="_blank" >http://www.elis.sk/download_file.php?product_id=7503&session_id=p837ql6mq8aer9601ekbmlrve6</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.4149/BLL_2022_006" target="_blank" >10.4149/BLL_2022_006</a>

Result language

angličtina

Original language name

Effect of immunosuppressive therapy in infl ammatory cardiomyopathy: data from The Czech Inflammatory Cardiomyopathy Immunosuppressive Trial.

Original language description

INTRODUCTION: The indications for specifi c treatment in the cases of infl ammatory cardiomyopathy are based on limited data from several small clinical trials. AIM: A comparison of the effect of two dose regimens of combined immunosuppressive therapy by adding them to conventional heart failure therapy and comparing them with conventional heart failure therapy alone in patients with infl ammatory cardiomyopathy. METHODS AND STUDY POPULATION: We enrolled 20 patients; mean age 46.10±7.33 years, duration of symptoms <6 months, LVEF ≤40 %, NYHA class II–IV, with biopsy-proven myocarditis. Patients were randomly separated into groups treated with immunosuppressive therapy in addition to conventional heart failure therapy or to a group treated with conventional heart failure therapy alone. Clinical and echocardiographic parameters were evaluated. RESULTS: The baseline values of LVEF in the group of immunosuppressive therapy (LVEF 22.3±4.7 %) were similar to those in the group treated with conventional heart failure therapy (LVEF 21.7±4.7 %; p=0.757). After twelve months there was no statistically signifi cant difference in LVEF between the two studied groups (LVEF 33.7±9.5 % for the immunosuppressive therapy group and 41.3±13.0 % for the conventional therapy group; p=0.175). CONCLUSION: In our study population, we proved no positive effect of combined immunosuppressive therapy on the left ventricular function over 12 months. The main limitation of the study is the small number of enrolled patients (Tab. 4, Fig. 1, Ref. 35). Text in PDF www.elis.sk

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30201 - Cardiac and Cardiovascular systems

Project

—

Continuities

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Publication year

2022

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Bratislava Medical Journal

ISSN

0006-9248

e-ISSN

1336-0345

Volume of the periodical

123

Issue of the periodical within the volume

1.1.2022

Country of publishing house

SK - SLOVAKIA

Number of pages

7

Pages from-to

37-43

UT code for WoS article

000748938700006

EID of the result in the Scopus database

2-s2.0-85123036945